moxalactam has been researched along with Peritonitis in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 15 (75.00) | 18.7374 |
1990's | 4 (20.00) | 18.2507 |
2000's | 1 (5.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Daly, JM; Duff, M; Freeman, TA; Fuortes, M; Hilbert, DW; Matsuda, T; Stapleton, PP | 1 |
Harada, Y; Nagata, W; Narisada, M; Otsuka, H; Yamada, H; Yoshida, T; Yoshioka, M | 1 |
McCall, CE; Pegram, PS; Salzer, W | 1 |
Dunlop, WE; Fabian, TC; Stone, HH; Strom, PR | 1 |
Dupeyron, JP; Peter, JD; Rigolot, JC | 1 |
Abe, H; Bekki, E; Hashimoto, I; Hirasawa, S; Katoh, H; Matsuda, S; Mikami, J; Nakamura, T; Sawada, Y | 1 |
Kline, BJ; Kronfol, NO; Polk, RE; Stephens, NM | 1 |
Isobe, H; Kotou, K; Motomura, K; Nawata, H; Sakai, H; Satoh, M | 1 |
Katoh, H; Nagamachi, Y; Shiojima, M; Takenoshita, S; Tsukada, K | 1 |
Aparicio, M; Bouchet, JL; Bourdenx, JP; Demotes-Mainard, F; Dupoux, J; Potaux, L; Quentin, C; Vinçon, G | 1 |
Berle, P; Hitschold, T; Queck, M | 1 |
Wilson, SE | 1 |
Danziger, LH; Ferron, JL; Gauderer, MW; Gordon, N; Hau, T; Stellato, TA | 1 |
Boswick, JA; Duma, RJ; Echols, RM; Jemsek, JG; Lerner, R; Lewis, RT; Najem, AZ; Press, RA; Rittenbury, MS; Wilson, SE | 1 |
Fond, G; Godard, J; Mahul, P; Motin, J; Perrot, D; Reverdy, ME | 1 |
Apicella, MA; Morse, GD; Walshe, JJ | 1 |
Hosutt, JA; Lentnek, AL; McDevitt, JT; Nichols, RL; Wikler, MA | 1 |
Müller, M; Wittmann, DH | 1 |
Frommelt, L; Teichmann, W; Wittmann, DH | 1 |
Fry, DE; Polk, HC; Trachtenberg, L | 1 |
2 review(s) available for moxalactam and Peritonitis
Article | Year |
---|---|
Discovery and development of Moxalactam (6059-S): the chemistry and biology of 1-oxacephems.
Topics: Animals; Antibodies, Bacterial; Cephalosporins; Cephamycins; Chemical Phenomena; Chemistry; Dogs; Drug Resistance, Microbial; Female; Guinea Pigs; Haplorhini; Humans; Kidney; Kinetics; Male; Mice; Moxalactam; Peritonitis; Rabbits; Rats; Reproduction | 1981 |
Moxalactam vs tobramycin-clindamycin. A randomized trial in secondary peritonitis.
Topics: Abscess; Adolescent; Adult; Bacteroides Infections; Clindamycin; Clinical Trials as Topic; Combined Modality Therapy; Drug Therapy, Combination; Escherichia coli Infections; Humans; Hypoprothrombinemias; Infant, Newborn; Middle Aged; Moxalactam; Peritonitis; Premedication; Prospective Studies; Random Allocation; Sepsis; Streptococcal Infections; Surgical Wound Infection; Tobramycin | 1988 |
6 trial(s) available for moxalactam and Peritonitis
Article | Year |
---|---|
Third-generation cephalosporins for polymicrobial surgical sepsis.
Topics: Abscess; Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Child; Clindamycin; Clinical Trials as Topic; Female; Gentamicins; Humans; Kidney Diseases; Male; Middle Aged; Moxalactam; Peritoneal Diseases; Peritonitis; Postoperative Complications; Random Allocation; Surgical Wound Infection | 1983 |
[Effectiveness of infection prevention with latamoxef in vaginal hysterectomy. A prospective study].
Topics: Adult; Female; Humans; Hysterectomy, Vaginal; Injections, Intravenous; Moxalactam; Peritonitis; Premedication; Prospective Studies; Risk Factors; Surgical Wound Infection; Urinary Tract Infections | 1991 |
Cephalosporin therapy in intra-abdominal infection: comparative studies of cefotetan, latamoxef and cefoxitin.
Topics: Cefotetan; Cefoxitin; Drug Evaluation; Humans; Moxalactam; Peritonitis; Random Allocation | 1988 |
Moxalactam vs tobramycin-clindamycin. A randomized trial in secondary peritonitis.
Topics: Abscess; Adolescent; Adult; Bacteroides Infections; Clindamycin; Clinical Trials as Topic; Combined Modality Therapy; Drug Therapy, Combination; Escherichia coli Infections; Humans; Hypoprothrombinemias; Infant, Newborn; Middle Aged; Moxalactam; Peritonitis; Premedication; Prospective Studies; Random Allocation; Sepsis; Streptococcal Infections; Surgical Wound Infection; Tobramycin | 1988 |
Cephalosporin therapy in intraabdominal infections. A multicenter randomized, comparative study of cefotetan, moxalactam, and cefoxitin.
Topics: Bacterial Infections; Cefotetan; Cefoxitin; Cephamycins; Clinical Trials as Topic; Humans; Moxalactam; Peritonitis; Prospective Studies; Random Allocation; Time Factors | 1988 |
Coagulopathy associated with extended-spectrum cephalosporins in patients with serious infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefotaxime; Ceftizoxime; Cephalosporins; Double-Blind Method; Female; Humans; Hypoprothrombinemias; Male; Middle Aged; Moxalactam; Peritonitis; Pneumonia; Prothrombin Time; Random Allocation | 1987 |
13 other study(ies) available for moxalactam and Peritonitis
Article | Year |
---|---|
Lysis-deficient bacteriophage therapy decreases endotoxin and inflammatory mediator release and improves survival in a murine peritonitis model.
Topics: Animals; Anti-Bacterial Agents; Ascitic Fluid; Bacteriophages; Biological Therapy; Colony Count, Microbial; Endotoxins; Escherichia coli; Escherichia coli Infections; Female; Inflammation Mediators; Interleukin-6; Mice; Mice, Inbred BALB C; Moxalactam; Peritonitis; Survival Analysis; Tumor Necrosis Factor-alpha | 2005 |
Clinical evaluation of moxalactam: evidence of decreased efficacy in gram-positive aerobic infections.
Topics: Adolescent; Adult; Aged; Anaerobiosis; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Female; Humans; Infant; Male; Meningitis; Middle Aged; Moxalactam; Peritonitis; Pneumonia; Sepsis; Urinary Tract Infections | 1983 |
[Moxalactam in complications of abdominal surgery].
Topics: Abdomen; Adolescent; Adult; Aged; Bacterial Infections; Cephalosporins; Cephamycins; Humans; Middle Aged; Moxalactam; Peritonitis; Postoperative Complications | 1983 |
[Clinical studies on 6059-S for acute peritonitis. Clinical effect and tissue concentration (author's transl)].
Topics: Acute Disease; Adolescent; Adult; Aged; Body Fluids; Cephalosporins; Cephamycins; Child; Drug Evaluation; Female; Humans; Male; Middle Aged; Moxalactam; Peritonitis; Tissue Distribution | 1981 |
Peritoneal absorption of moxalactam.
Topics: Absorption; Adult; Ascitic Fluid; Female; Humans; Leukocyte Count; Male; Middle Aged; Moxalactam; Peritoneal Dialysis; Peritonitis; Time Factors | 1983 |
Spontaneous bacterial empyema and peritonitis caused by Morganella morganii.
Topics: Empyema, Pleural; Humans; Male; Middle Aged; Moxalactam; Peritonitis; Proteus Infections | 1994 |
Mortality rate and bacteremia, endotoxin, and endothelin-1 levels in antibiotic therapy for E. coli septic peritonitis.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Endothelins; Endotoxins; Escherichia coli Infections; Injections, Intraperitoneal; Moxalactam; Peritonitis; Prognosis; Rats; Rats, Wistar; Survival Analysis | 1993 |
Pharmacokinetic considerations for treatment of bacterial peritonitis during continuous ambulatory peritoneal dialysis.
Topics: Adult; Aged; Bacterial Infections; Cefotaxime; Female; Fosfomycin; Humans; Male; Middle Aged; Moxalactam; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1991 |
[Erythromycin and latamoxef in the initial treatment of diffuse peritonitis with visceral failure].
Topics: Acute Disease; Acute Kidney Injury; Adult; Aged; Drug Therapy, Combination; Erythromycin; Female; Humans; Male; Middle Aged; Moxalactam; Multiple Organ Failure; Peritonitis | 1987 |
Absorption of intraperitoneal antibiotics.
Topics: Absorption; Anti-Bacterial Agents; Cefamandole; Humans; Infusions, Parenteral; Kidney Failure, Chronic; Moxalactam; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Radioimmunoassay; Tobramycin; Vancomycin | 1988 |
Patient stratification in intra-abdominal infection.
Topics: Aged; Bacteria; Bacterial Infections; Cefotetan; Cefuroxime; Cephalosporins; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Peritonitis | 1987 |
[Significance of the causative agent of infection for therapy of purulent peritonitis].
Topics: Abscess; Anti-Bacterial Agents; Bacterial Infections; Bacteroides Infections; Clostridium Infections; Drug Therapy, Combination; Escherichia coli Infections; Female; Humans; Middle Aged; Moxalactam; Peritonitis | 1985 |
Serum kinetics of intraperitoneal moxalactam.
Topics: Absorption; Animals; Dogs; Infusions, Parenteral; Kinetics; Moxalactam; Peritoneal Cavity; Peritonitis; Therapeutic Irrigation; Time Factors | 1986 |